What Has Been the Growth of the Cell Therapy Human Raw Materials Market So Far?
The cell therapy human raw materials market has seen considerable growth due to a variety of factors.
• The cell therapy human raw materials market has seen exponential growth in recent years. It will increase from $2.82 billion in 2024 to $3.39 billion in 2025, reflecting a compound annual growth rate (CAGR) of 20.4%.
The growth drivers include the rise in chronic diseases, a growing elderly population, high demand for regenerative medicines, government funding, and an increase in healthcare spending.
What Is the Forecasted Market Size and Growth Rate for The Cell Therapy Human Raw Materials Market Size In The Coming Years?
The cell therapy human raw materials market is expected to maintain its strong growth trajectory in upcoming years.
• The cell therapy human raw materials market is projected to reach $7.05 billion by 2029, growing at a CAGR of 20.1%.
Growth is fueled by expanding therapeutic applications, patient awareness, favorable regulatory frameworks, a growing biopharmaceutical sector, and improved manufacturing processes. Trends include allogeneic therapy adoption, AI integration, off-the-shelf cell therapies, 3D bioprinting, and hybrid cell therapy development.
What Factors Are Driving Growth In The Cell Therapy Human Raw Materials Market?
The increasing adoption of regenerative medicine is expected to boost the cell therapy human raw materials market. This field, which aims to repair, replace, or regenerate damaged tissues and organs, benefits from technological advancements, better understanding of cellular processes, a surge in demand for personalized medicine, and its potential to meet unmet medical needs. Cell therapy and human raw materials are key in enabling cell-based treatments, ensuring standardized and reliable therapies for various conditions. For example, a report by the Alliance for Regenerative Medicine in August 2023 indicated that the number of global cell, gene, and tissue-engineering therapeutic developers grew by 101% from 1369 in Q1 2022 to 2760 in Q1 2023. Thus, the rise in regenerative medicine adoption is driving this market.
What Are The Main Segments Of The Global Cell Therapy Human Raw Materials Market?
The cell therapy human raw materials market covered in this report is segmented –
1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions
Subsegments:
1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)
2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum
3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides
4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants
5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers
Pre-Book The Cell Therapy Human Raw Materials Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Cell Therapy Human Raw Materials Market?
In the cell therapy human raw materials market, companies are focusing on the development of chemically defined cell culture mediums to accelerate cell therapy development. These mediums provide essential nutrients and conditions for cells to grow outside their natural environment. For example, in May 2023, Switzerland-based Lonza Group AG launched TheraPEAK T-VIVO Cell Culture Medium, a chemically defined, serum-free medium that ensures consistency, safety, and regulatory compliance in cell therapy manufacturing. The medium eliminates animal components and supports regulatory-friendly practices, improving safety and quality.
Who Are the Key Players In The Cell Therapy Human Raw Materials Market?
Major companies operating in the cell therapy human raw materials market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• GE Healthcare
• Corning Incorporated
• Lonza Group Ltd.
• Grifols S.A.
• WuXi AppTec
• Catalent Inc.
• Sartorius AG
• Charles River Laboratories
• Bio-Rad Laboratories Inc.
• Pall Corporation
• Bio-Techne Corporation
• Miltenyi Biotec
• Actylis
• STEMCELL Technologies
• Takara Bio Inc.
• Vericel Corporation
• ACROBiosystems
• BioIVT LLC
• Orgenesis Inc.
• PromoCell GMBH
• ViaCyte Inc.
• AllCells LLC
• Sartorius CellGenix GmbH
• Fujifilm Cellular Dynamics Inc.
• Mesoblast Limited
• RoosterBio Inc.
• Thermogenesis Holdings Inc.
What Is The Most Dominant Region In The Cell Therapy Human Raw Materials Market?
North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
